Sotera Health Company (NASDAQ: SHC) is a Healthcare company (Medical - Diagnostics & Research) with a market capitalization of $4.6B. The Maz Rating grades it against the other companies in its sector.
Sotera Health Company's current Maz Rating and its five factor grades are for members: log in to see them.
At $16.05, Sotera Health Company trades at 26.6x trailing earnings, 3.7x sales and 6.3x book value, with an EV/EBITDA of 11.9. Over the last twelve months it generated about $1.2B of revenue and $172M of net income. It runs a gross margin of 54.4%, an operating margin of 36.0% and a net margin of 14.1%. It shows return on equity of 26.4%, return on invested capital of 8.8% and a free cash flow yield of 3.0%. On the balance sheet: a debt-to-equity ratio of 3.10 and a current ratio of 3.13. Over the past 52 weeks the share price ranged from $13.09 to $19.85, with a beta of 1.93.
Sotera Health Company does not currently pay a dividend.
12 Wall Street analyst ratings cover the stock: 11 Buy and 1 Sell, for a Buy consensus. This is the sell side's view, separate from the Maz Rating.
Figures are trailing twelve months unless stated. The Maz Rating and Maz Dividend Score rank a company against its own sector; they are not price targets or recommendations.